Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008 KL Vine, L Matesic, JM Locke, M Ranson, D Skropeta Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2009 | 353 | 2009 |
Methods to enhance the metabolic stability of peptide-based PET radiopharmaceuticals BJ Evans, AT King, A Katsifis, L Matesic, JF Jamie Molecules 25 (10), 2314, 2020 | 132 | 2020 |
N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents L Matesic, JM Locke, JB Bremner, SG Pyne, D Skropeta, M Ranson, ... Bioorganic & medicinal chemistry 16 (6), 3118-3124, 2008 | 119 | 2008 |
Recent highlights in the development of isatin-based anticancer agents KL Vine, L Matesic, JM Locke, D Skropeta Adv. Anticancer Agents Med. Chem 2, 254-312, 2013 | 87 | 2013 |
Ascertaining the Suitability of Aryl Sulfonyl Fluorides for [18F]Radiochemistry Applications: A Systematic Investigation using Microfluidics L Matesic, NA Wyatt, BH Fraser, MP Roberts, TQ Pham, I Greguric The Journal of organic chemistry 78 (22), 11262-11270, 2013 | 82 | 2013 |
Synthesis and anti-leukaemic activity of pyrrolo [3, 2, 1-hi] indole-1, 2-diones, pyrrolo [3, 2, 1-ij] quinoline-1, 2-diones and other polycyclic isatin derivatives L Matesic, JM Locke, KL Vine, M Ranson, JB Bremner, D Skropeta Tetrahedron 68 (34), 6810-6819, 2012 | 70 | 2012 |
Optimization of nucleophilic 18F radiofluorinations using a microfluidic reaction approach G Pascali, L Matesic, TL Collier, N Wyatt, BH Fraser, TQ Pham, ... nature protocols 9 (9), 2017-2029, 2014 | 35 | 2014 |
Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor VI Chandran, L Matesic, JM Locke, D Skropeta, M Ranson, KL Vine Cancer letters 316 (2), 151-156, 2012 | 33 | 2012 |
Synthesis and hydrolytic evaluation of acid-labile imine-linked cytotoxic isatin model systems L Matesic, JM Locke, KL Vine, M Ranson, JB Bremner, D Skropeta Bioorganic & medicinal chemistry 19 (5), 1771-1778, 2011 | 33 | 2011 |
Dose-on-demand production of diverse 18F-radiotracers for preclinical applications using a continuous flow microfluidic system L Matesic, A Kallinen, I Greguric, G Pascali Nuclear Medicine and Biology 52, 24-31, 2017 | 31 | 2017 |
Hardware and software modifications on the Advion NanoTek microfluidic platform to extend flexibility for radiochemical synthesis G Pascali, A Berton, M DeSimone, N Wyatt, L Matesic, I Greguric, ... Applied Radiation and Isotopes 84, 40-47, 2014 | 26 | 2014 |
Targeting urokinase and the transferrin receptor with novel, anti-mitotic N-alkylisatin cytotoxin conjugates causes selective cancer cell death and reduces tumor growth K L Vine, V Indira Chandran, J M Locke, L Matesic, J Lee, D Skropeta, ... Current Cancer Drug Targets 12 (1), 64-73, 2012 | 26 | 2012 |
Synthesis, bioconjugation and stability studies of [18F]ethenesulfonyl fluoride B Zhang, G Pascali, N Wyatt, L Matesic, MA Klenner, TR Sia, AJ Guastella, ... Journal of Labelled Compounds and Radiopharmaceuticals 61 (11), 847-856, 2018 | 24 | 2018 |
Sulfur-fluorine bond in PET radiochemistry G Pascali, L Matesic, B Zhang, AT King, AJ Robinson, AT Ung, BH Fraser EJNMMI Radiopharmacy and Chemistry 2, 1-18, 2017 | 23 | 2017 |
How far are we from dose on demand of short-lived radiopharmaceuticals G Pascali, L Matesic Perspectives on nuclear medicine for molecular diagnosis and integrated …, 2016 | 22 | 2016 |
A new class of fluorinated 5-pyrrolidinylsulfonyl isatin caspase inhibitors for PET imaging of apoptosis AM Krause-Heuer, NR Howell, L Matesic, G Dhand, EL Young, L Burgess, ... MedChemComm 4 (2), 347-352, 2013 | 21 | 2013 |
In Vivo Evaluation of Radiofluorinated Caspase-3/7 Inhibitors as Radiotracers for Apoptosis Imaging and Comparison with [18F]ML-10 in a Stroke Model in the Rat M Médoc, M Dhilly, L Matesic, J Toutain, AM Krause-Heuer, J Delamare, ... Molecular imaging and biology 18, 117-126, 2016 | 18 | 2016 |
Tolerance of water in microfluidic radiofluorinations: a potential methodological shift? G Pascali, M De Simone, L Matesic, I Greguric, PA Salvadori Journal of Flow Chemistry 4 (2), 86-91, 2014 | 10 | 2014 |
[18F] Fluorination optimisation and the fully automated production of [18F] MEL050 using a microfluidic system L Matesic, A Kallinen, NA Wyatt, TQ Pham, I Greguric, G Pascali Australian Journal of Chemistry 68 (1), 69-71, 2014 | 9 | 2014 |
An investigation into the in vitro metabolic stability of aryl sulfonyl fluorides for their application in medicinal chemistry and radiochemistry AT King, L Matesic, ST Keaveney, JF Jamie Molecular Pharmaceutics 20 (2), 1061-1071, 2023 | 7 | 2023 |